Asthma
Erasmus University publishes research in asthma
Published in Respiratory Therapeutics Week, November 23rd, 2009
According to recent research from Netherlands, "In budesonide/formoterol (Symbicort ® Turbuhaler ®, AstraZeneca, Lund, Sweden) maintenance and reliever therapy ( SMART), patients with asthma take a daily maintenance dose of budesonide/formoterol, with the option of taking additional doses for symptom relief instead of a short-acting beta(2)-agonist ( SABA). This study assesses the cost-effectiveness of SMART compared with usual care in patients with mild-to-moderate persistent asthma treated by general practitioners in the Netherlands from a societal perspective."
"The study was linked to a randomized, active-controlled, open-label, multicenter, 12-month...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- Columbia University Medical Center
Drugs to treat anemia in cancer patients linked to thromboembolism - Imperial College London
Drug shrinks lung cancer tumors in mice - Allergies
Studies from RIKEN describe new findings in allergies - Allergies
Study data from Yonsei University update knowledge of allergies - Asthma
Findings in asthma reported from Hoshi University - Asthma
Studies by T.A.C. Nizet and co-authors describe new findings in asthma - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
